These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 13626861)

  • 1. Drugs which alter the metabolism of vasoactive monoamines.
    SJOERDSMA A
    Am J Cardiol; 1959 Mar; 3(3):273-5. PubMed ID: 13626861
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolism of vasoactive substances in the lung].
    Kokubu T; Ueda E; Akutsu H; Ito T
    Nihon Rinsho; 1971 Dec; 29(12):3051-60. PubMed ID: 4335196
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inactivation of vasoactive substances in the canine lung].
    Wagai F; Uetsuka N; Kinoshita M; Watanabe H; Kitamura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Nov; 23(11):1337-42. PubMed ID: 4094215
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vasoactive substance and the lung].
    Kitamura S
    Kokyu To Junkan; 1973 Aug; 21(8):688-700. PubMed ID: 4354545
    [No Abstract]   [Full Text] [Related]  

  • 5. A pharmacological study of certain alkoxyalkylamines.
    MIYA TS; EDWARDS LD
    J Am Pharm Assoc Am Pharm Assoc; 1953 Feb; 42(2):107-10. PubMed ID: 13034643
    [No Abstract]   [Full Text] [Related]  

  • 6. [Metabolic function of the lung].
    Biron P
    Union Med Can; 1968 Jan; 97(1):3. PubMed ID: 5652324
    [No Abstract]   [Full Text] [Related]  

  • 7. Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction.
    Burnstock G
    J Anat; 1999 Apr; 194 ( Pt 3)(Pt 3):335-42. PubMed ID: 10386771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive substances as regulators of renal growth.
    Wolf G
    Exp Nephrol; 1993; 1(3):141-51. PubMed ID: 8081963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oenethyl in spinal anesthesia.
    ZELDIS N
    Curr Res Anesth Analg; 1953; 32(1):27-36. PubMed ID: 13043228
    [No Abstract]   [Full Text] [Related]  

  • 10. The pharmacology of some new cycloöctylalkylamines. I. Vasopressor activity and the effect on the heart rate.
    KAHL RJ; JOHNSON WE; O'DAY DW
    J Am Pharm Assoc Am Pharm Assoc; 1958 Jun; 47(6):446-50. PubMed ID: 13549294
    [No Abstract]   [Full Text] [Related]  

  • 11. Fundamental basis of the specificity of pressor and depressor amines in their vascular effects. V. Theoretical fundaments; drug receptor linkage.
    CROXATTO R; HUIDOBRO F
    Arch Int Pharmacodyn Ther; 1956 Apr; 106(1-2):207-43. PubMed ID: 13328228
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vascular complications in diabetes mellitus: role of endothelial dysfunction].
    Stehouwer CD
    Ned Tijdschr Geneeskd; 1996 Apr; 140(16):870-4. PubMed ID: 8692297
    [No Abstract]   [Full Text] [Related]  

  • 13. Preventive treatment of graft coronary vascular disease: the potential role of vasodilator therapy.
    Gibbons GH
    J Heart Lung Transplant; 1992; 11(3 Pt 2):S22-7. PubMed ID: 1622995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temperature and concentration effects on penetration of N-octylamine through human skin in situ.
    Cummings EG
    J Invest Dermatol; 1969 Jul; 53(1):64-70. PubMed ID: 5793138
    [No Abstract]   [Full Text] [Related]  

  • 15. The lung as a metabolic organ.
    Said SI
    N Engl J Med; 1968 Dec; 279(24):1330-4. PubMed ID: 4880441
    [No Abstract]   [Full Text] [Related]  

  • 16. Bioassay of small amounts of vasoactive substances.
    KINGSOLVER WR; DONTAS AS; HOOBLER SW
    J Appl Physiol; 1953 Jul; 6(1):57-64. PubMed ID: 13084521
    [No Abstract]   [Full Text] [Related]  

  • 17. Regional differences in response of terminal vascular bed to vasoactive agents.
    ZWEIFACH BW; METZ DB
    Am J Physiol; 1955 Jul; 182(1):155-65. PubMed ID: 13248960
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of vasoactive materials on the peripheral blood vessels in the hamster.
    AKERS RP; ZWEIFACH BW
    Am J Physiol; 1955 Dec; 183(3):529-34. PubMed ID: 13283071
    [No Abstract]   [Full Text] [Related]  

  • 19. [The behavior of fat and carbohydrate metabolites following administration of vasoactive substances].
    Hammerl H; Kränzl C; Pichler O; Studlar M
    Verh Dtsch Ges Inn Med; 1967; 73():793-7. PubMed ID: 5591842
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of some vasoactive drugs on fibrinolytic activity.
    WEINER M; DE CRINIS K; REDISCH W; STEELE JM
    Circulation; 1959 Jun; 19(6):845-8. PubMed ID: 13663173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.